top of page
  • rgrosslaw

RGLaw Appeals Rejection of Application Directed to a Vaccine Against Influenza

RGLaw secured a favorable result for its client for a patent application directed to Polyvalent Fusion Protein Vaccine Against Influenza. Upon receiving a Final Office Action, Roy Gross filed a Pre-Appeal Brief which successfully persuaded a three-person panel at the USPTO that the patent specification is enabling of the claims and that claimed invention is novel and non-obvious over the cited prior art. Issuance of a patent containing all pending claims is expected in due course

29 views0 comments

Recent Posts

See All

RGrossLaw Issues 66 Utility Patents in 2018

RGrossLaw Issues 66 Utility Patents in 2018 and is listed as one of the Top Patent Firms in the United States. Continued growth

RGLaw Issues First US Patent

The newly established Roy Gross Law Firm, LLC, ("RGLaw") is proud to announce the issuance of its first U.S. Patent on January 26, 2016 — U.S. Patent Number 9,242,003 entitled "Surface-Modified Heavy

bottom of page